We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

AnaSpec Develops HTS Assay Kits for Screening HCV NS3/4A

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

AnaSpec has announced that it has developed the HTS assay kits for screening HCV NS3/4a. 

EnzoLyte™ assay kits are designed for the detection and quantification of NS3/4A protease activity at subnanomolar concentrations. They can be used in 96- or 384-well microplate format.

There are three assay kits to choose from depending on what wavelength is used for monitoring the cleavage of the FRET substrate. 

Convenient mix-and-read format and one-step procedure make EnzoLyte Assay Kits ideal for high-throughput screening. 
 
EnzoLyte™ 490 HCV Assay Kit: 

Peptide substrate paired with Dabcyl (fluorophore) and Edans (quencher).  Fluorescence can be continuously monitored at Ex/Em=340/490nm. Kit size: 500 assays.
 
EnzoLyte™ 520 HCV Assay Kit: 

Peptide substrate paired with 5-FAM (fluorophore) and QXL™ 520 (quencher).  Fluorescence can be continuously monitored at Ex/Em=490/520 nm. Kit size: 100 assays.
 
EnzoLyte™ 620 HCV Assay Kit:

Peptide substrate paired with HiLyte Fluor™ TR (fluorophore) and QXL™ 610 (quencher). With near red emission wavelength, this FRET peptide avoids the autofluorescence interference associated with most test compounds.

Fluorescence can be continuously monitored at Ex/Em=590/620nm. Kit size: 100 assays.